- Quote, Chart, News
- Snapshot
- Company Report
- Quotes
- Charts
- Key Developments
Recent News- Research
- SEC Filings
- Advisor FYI
- CAPS
- StockScouter
- Earnings Estimates
- Analyst Ratings
- Financial Results
- Insider Trading
- Ownership
- Message Board
- Guided Research
- Research Wizard
- Find Stocks
- Stock Screener
- Stock Power Searches
- Top-Rated Stocks
- Related Links
- Quote Watchlist
- Expert Picks
- E-mail & Alerts
- IPO Center
- Message Boards
- Capital Gains Analysis
News resources
| LM Ericsson Telephone ADR Reptg 1 Ord Shs Class B (ERIC) | 4 stories... |
| Incyte Corp (INCY) | 3 stories... |
| Goldman Sachs Group Inc (GS) | 3 stories... |
| Nortel Networks Corp (NRTLQ) | 2 stories... |
| Microsoft Corp (MSFT) | 2 stories... |
| advertisement |
Pfizer Inc: All Recent News
- Final Glance: Pharmaceuticals companies 11/24/2009
- NEW YORK (AP) - Shares of some top pharmaceuticals companies were mixed at the close of trading:... Associated Press
- 4 Platform Drugmakers to Invest In 11/24/2009
- No special shoes required. At Motley Fool
- Big Winners for Small Investors 11/24/2009
- The secret to 50%-per-year returns is revealed. At Motley Fool
- Early Glance: Pharmaceuticals companies 11/24/2009
- NEW YORK (AP) - Shares of some top pharmaceuticals companies are mixed at 10 a.m.:... Associated Press
- A Rorschach on Health Care? Pfizer Hit With $28M in Punitives 11/24/2009
- ... At Wall Street Journal
- Zeroing In On What's Important 11/23/2009
- Pfizer's Amy Schulman on how she makes the most of every minute. At Forbes
- Pfizer told to pay $28 mln damages in Prempro case 11/23/2009
- ... At Thomson Reuters
- Sage Advice On Vytorin 11/23/2009
- So what is the bottom line on the continuing kerfluffle over the cholesterol drugs Zetia and Vytorin, sold by Merck? The basic problem is this: What should patients and doctors do when insufficient data is collected on a new medicine? Merck has lots of studies showing that Zetia lowers cholesterol, but there are no studies that ... At Forbes
- Speculating On $1,500 Gold 11/23/2009
- If you think the price of gold can go 30% higher by next June, then this is a trade you'll like. At Forbes
- The Side Effect of Developing Obesity Drugs 11/23/2009
- The FDA is fickle when it comes to weight-loss drugs. At Motley Fool
- Healthcare Stocks: Safe and Speculative 11/23/2009
- NEW YORK (TheStreet) -- Allos Therapeutics is the best speculative bet in the sector. Watch this video for the safest and biggest growth stock to add to your portfolio. At TheStreet.com
- Does Pfizer CEO Regret Sale of Consumer Products to J&J? 11/23/2009
- ... At Wall Street Journal
- Pfizer, Immunovaccine in animal vaccine deal 11/23/2009
- NEW YORK (AP) - Immunovaccine Inc. said Monday that Pfizer Inc., the world's largest drugmaker, is licensing its technology for use in vaccines for cattle. Associated Press
- Jeff Saut: Was the Long Position a Bad Trade? 11/23/2009
- Editor's Note: The following article was written by Raymond James Chief Investment Strategist Jeff Saut. It has been reproduced with permission for the benefit of the Minyanville community. I asked the obligatory question: “How do you decide when to make a trade?” “Through experience ” he says propping his foot up on a small fold-out seat screwed to his post. “Over the course of 18 years as a specialist I’ve had every type of experience -- up market and down market people getting shot wars you name it -- and you learn how to react based on those... At Minyanville
- ($) Sanofi Has Lots of Upside Catalysts 11/23/2009
- Looks like the patent worries aren't so dire after all. At TheStreet.com
- More News
- Market Report
- News by Symbol
- Today's Investing Articles
- Breaking News
- News by Topic
- News by Industry
- MSNBC News
- Data providers
- Copyright © 2009 Thomson Reuters. Click for Restrictions.
- Quotes supplied by Interactive Data Real-Time Services.